Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 245-589-7 | CAS number: 23328-87-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 23 May 2018 to 05 July 2018
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 018
- Report date:
- 2018
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 2008
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Version / remarks:
- 2003
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- GLP-Landesleitstelle Bayern, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, Schwabach, Germany
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-heptadecyl-1H-imidazole
- EC Number:
- 245-589-7
- EC Name:
- 2-heptadecyl-1H-imidazole
- Cas Number:
- 23328-87-2
- Molecular formula:
- C20H38N2
- IUPAC Name:
- 2-heptadecyl-1H-imidazole
1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- other: CBA/CaOlaHsd
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Envigo (formed partially from Harlan in September 2015), 5800 AN Venray, The Netherlands
- Females nulliparous and non-pregnant: yes
- Microbiological status of animals, when known: SPF
- Age at study initiation: 8-9 weeks
- Housing: the animals were kept in groups of 5 animals in IVC cages, type II L, polysulphone cages on Altromin saw fibre bedding
- Diet: Altromin 1324 maintenance diet, ad libitum
- Water: tap water, ad libitum
- Acclimation period: at least five days
- Indication of any skin lesions: none
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 3
- Humidity (%):55 ± 10
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 3%, 6.25% and 12.5% (w/v)
- No. of animals per dose:
- 5
- Details on study design:
- PRE-SCREEN TESTS: two animals per dose were treated by topical application with the test item on three consecutive days at concentrations of 6.25 and 12.5 % in acetone/olive oil 4:1 (AOO) to the entire dorsal surface of each ear. One further animal was treated with 100 % AOO and served as negative control.
- Compound solubility: the vehicle was chosen as it was suitable at the highest concentration.
- Irritation: the mice were observed daily for local skin irritation to the application site.
- Systemic toxicity: the mice were observed daily for any clinical signs of systemic toxicity, and body weights were recorded pre-test and prior to termination.
- Ear thickness measurements: performed on day 1 (pre-dose), day 3 (approximately 48 hours after the first dose) and day 6.
- Erythema scores: No erythema (0), very slight erythema (1), well-defined erythema (2), moderate to severe erythema (3), severe erythema to eschar formation preventing grading of erythema (4).
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: 3H-methyl thymidine (3HTdR) incorporation determined by β-scintillation counting
- Criteria used to consider a positive response: A substance is regarded as a “sensitizer” in the LLNA if at least one concentration of the test item results in a 3-fold or greater increase in 3HTdR incorporation into lymph node cells of the test group animals, relative to that recorded for the lymph nodes of control group animals. Any test item failing to produce a 3-fold or greater increase in 3HTdR incorporation is classified as a "non-sensitizer".
If the results allowed the EC3 value could also be calculated. The EC3 value is the concentration of test item expected to cause a 3-fold increase in 3HTdR incorporation. The equation used for the calculation of EC3 is:
EC3 = c + [[(3-d)/(b-d)] x (a-c)]
a = lowest concentration giving stimulation index >3
b = actual stimulation index caused by 'a'
c = highest concentration failing to produce a stimulation index of 3
d = actual stimulation index caused by 'c'
- Other: The animals were observed for signs of toxicity prior to the application and once daily after treatment. The body weight was recorded prior to the application and at the end of the test period (prior to the treatment with 3HTdR).
TREATMENT PREPARATION AND ADMINISTRATION: 25 μL of the test compound in concentrations of 3%, 6.25% and 12.5% (w/v) in AOO and negative control (AOO) was applied to the dorsal surface of each ear of each mouse on Day 1, 2 and 3. On Day 6 an injection of 250 μL phosphate buffered saline (PBS) containing 20 μCi of 3H-methyl thymidine (3H-TdR) was made into the tail vein of each experimental mouse. Five hours later, the draining auricular lymph node of each ear was excised into PBS. A single cell suspension of pooled lymph node cells was prepared per experimental group by gentle mechanical disaggregation through a 200-mesh stainless steel gauze and rinsed with PBS. The precipitates were incubated for approximately 18 h at approximately 4 °C, centrifuged, resuspended in 1 mL 5% TCA (trichloroacetic acid) and transferred to 7 mL scintillation fluid before β-scintillation counting. - Positive control substance(s):
- other: Phenylene- diamine
Results and discussion
- Positive control results:
- A positive control was performed concomitantly using 5 animals, the result showed the positive-control substance exceeded the stimulation index of 3 confirming the reliability of the test system.
In vivo (LLNA)
Resultsopen allclose all
- Key result
- Parameter:
- SI
- Value:
- ca. 1
- Test group / Remarks:
- 3%
- Key result
- Parameter:
- SI
- Value:
- ca. 1.2
- Test group / Remarks:
- 6.25 %
- Key result
- Parameter:
- SI
- Value:
- ca. 1.4
- Test group / Remarks:
- 12.5 %
- Cellular proliferation data / Observations:
- DETAILS ON STIMULATION INDEX CALCULATION
The SI of the 3, 6.25 and 12.5 % treatment group was 1.0, 1.2 and 1.4, respectively.
EC3 CALCULATION
The EC3 value could not be calculated as the stimulation indices of all concentrations were below 3.
CLINICAL OBSERVATIONS:
All animals survived throughout the test period without showing any clinical signs.
BODY WEIGHTS
All animals showed the expected weight development, which includes a weight loss of up to 2 g throughout the study.
Any other information on results incl. tables
Table 1: Radioactive Determination of the Test Substance Groups – Main Study
POS |
CPM |
Test Item |
Conc. [%] |
Animal Number |
DPM |
DPM-mean background |
DPM / Node |
Stimulation Index |
51 |
8.0 |
Background Scinti and TCA |
|
|
14.0 |
|
|
|
52 |
6.0 |
|
11.0 |
|
|
|
||
53 |
6.0 |
|
12.0 |
|
|
|
||
54 |
6.0 |
|
12.0 |
|
|
|
||
55 |
9.0 |
|
17.0 |
|
|
|
||
MV |
7.0 |
MV |
13.2 |
0.0 |
0.0 |
0.0 |
||
SD |
1.3 |
SD |
2.1 |
|
|
|
||
26 |
1429.0 |
C17Z in AOO |
3 |
1 |
2866.0 |
2852.8 |
1426.4 |
0.9 |
27 |
1424.0 |
2 |
2857.0 |
2843.8 |
1421.9 |
0.9 |
||
28 |
1771.0 |
3 |
3556.0 |
3542.8 |
1771.4 |
1.1 |
||
29 |
1693.0 |
4 |
3405.0 |
3391.8 |
1695.9 |
1.1 |
||
30 |
1087.0 |
5 |
2178.0 |
2164.8 |
1082.4 |
0.7 |
||
MV |
1480.0 |
MV |
2972.4 |
2959.2 |
1479.6 |
1.0 |
||
SD |
240.9 |
SD |
486.5 |
486.5 |
243.3 |
0.2 |
||
31 |
1868.0 |
C17Z in AOO |
6.25 |
6 |
3747.0 |
3733.8 |
1866.9 |
1.2 |
32 |
1638.0* |
7 |
3297.0* |
n.d. |
n.d. |
n.d. |
||
33 |
1769.0 |
8 |
3553.0 |
3539.8 |
1769.9 |
1.1 |
||
34 |
1909.0 |
9" |
3842.0 |
3828.8 |
1914.4 |
1.2 |
||
35 |
1876.0 |
10 |
3784.0 |
3770.8 |
1885.4 |
1.2 |
||
MV |
1855.5 |
MV |
3731.5 |
3718.3 |
1859.2 |
1.2 |
||
SD |
52.3 |
SD |
108.5 |
108.5 |
54.2 |
0.0 |
||
36 |
1878.0 |
C17Z in AOO |
12.5 |
11 |
3817.0 |
3803.8 |
1901.9 |
1.2 |
37 |
1955.0 |
12 |
3926.0 |
3912.8 |
1956.4 |
1.3 |
||
38 |
2677.0 |
13 |
5395.0 |
5381.8 |
2690.9 |
1.7 |
||
39 |
1494.0 |
14 |
3010.0 |
2996.8 |
1498.4 |
1.0 |
||
40 |
2539.0 |
15 |
5121.0 |
5107.8 |
2553.9 |
1.6 |
||
MV |
2108.6 |
MV |
4253.8 |
4240.6 |
2120.3 |
1.4 |
||
SD |
438.8 |
SD |
883.1 |
883.1 |
441.6 |
0.3 |
||
41 |
1335.0 |
Negative Control AOO |
100 |
101 |
2676.0 |
2662.8 |
1331.4 |
|
42 |
1339.0 |
102 |
2690.0 |
2676.8 |
1338.4 |
|
||
43 |
1632.0 |
103 |
3274.0 |
3260.8 |
1630.4 |
|
||
44 |
1811.0 |
104 |
3657.0 |
3643.8 |
1821.9 |
|
||
45 |
1657.0 |
105 |
3328.0 |
3314.8 |
1657.4 |
|
||
MV |
1554.8 |
MV |
3125.0 |
3111.8 |
1555.9 |
1.0 |
||
SD |
188.1 |
SD |
384.0 |
384.0 |
192.0 |
|
POS = position in counter; CPM = counts per minute; Conc. = concentration; DPM = disintegrations per minute; * = outlier, failed Nalimov; n.d. = not determined; MV = mean value; SD = standard deviation; Szinti = scintillation fluid; TCA = trichloroacetic acid
If not noted individually, the results include both lymph nodes of an animal.
Applicant's summary and conclusion
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No 1272/2008.
- Conclusions:
- Consequently, according to OECD 429 the test item C17Z as described in this report is expected to have no sensitising properties and therefore should not be regarded as a dermal sensitiser.
According to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System) the test item C17Z has no obligatory labelling requirement for skin sensitisation and is unclassified. - Executive summary:
The test item C17Z was tested in a Local Lymph Node Assay (LLNA) in mice according to OECD guideline 429 and EU method B.42.
Three groups each of five female mice were treated with 3, 6.25 or 12.5% (w/v) test item concentration by topical application at the dorsum of each ear on three consecutive days. One negative control group was treated with the respective vehicle only (4:1 (v/v) acetone / olive oil).
The animals did not show any signs of systemic toxicity during the course of the study and no cases of mortality were observed.
Signs of local irritation (e.g. reddening of the ear skin, ear swelling) were also not observed during the study period.
A statistically significant increase in body weights was not observed in any of the groups treated with different concentrations of the test item in comparison to the vehicle control group.
Here, Stimulation Indices (S.I.) were determined with the test item at concentrations of 3, 6.25 and 12.5% (w/v) in AOO (4:1 (v/v) acetone/oliveoil), respectively.
A statistically significant difference in DPM/animal was not observed in any of the groups treated with different concentrations of the test item in comparison to the vehicle control group.
The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.The S.I. of the positive control group was 4.0.
The test item C17Z did not show skin sensitizing potential in this assay under the conditions of this study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.